$37.10 B
๐Ÿ‡จ๐Ÿ‡ณ China
Share price
Change (1 day)
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: $37.10 Billion

As of September 2021 BeiGene has a market cap of $37.10 Billion. This makes BeiGene the world's 536th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of BeiGene from 2016 to 2021

Year Market cap Change
2021$37.66 B56.75%
2020$24.03 B133.57%
2019$10.28 B23.44%
2018$8.33 B87.28%
2017$4.45 B269.44%
2016$1.20 B